TwinBeech Capital’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $482K | Sell |
23,676
-14,668
| -38% | -$298K | 0.01% | 493 |
|
|
2025
Q1 | $696K | Buy |
38,344
+3,786
| +11% | +$68.7K | 0.01% | 538 |
|
|
2024
Q4 | $873K | Sell |
34,558
-105,944
| -75% | -$2.68M | 0.01% | 397 |
|
|
2024
Q3 | $4.78M | Buy |
140,502
+103,497
| +280% | +$3.52M | 0.09% | 260 |
|
|
2024
Q2 | $1.37M | Buy |
37,005
+18,459
| +100% | +$683K | 0.03% | 372 |
|
|
2024
Q1 | $778K | Sell |
18,546
-18,631
| -50% | -$782K | 0.02% | 437 |
|
|
2023
Q4 | $1.47M | Sell |
37,177
-25,406
| -41% | -$1.01M | 0.02% | 445 |
|
|
2023
Q3 | $1.72M | Buy |
62,583
+44,207
| +241% | +$1.22M | 0.03% | 430 |
|
|
2023
Q2 | $623K | Sell |
18,376
-25,692
| -58% | -$872K | 0.01% | 496 |
|
|
2023
Q1 | $1.59M | Buy |
+44,068
| New | +$1.59M | 0.03% | 398 |
|
|
2022
Q4 | – | Sell |
-48,939
| Closed | -$1.38M | – | 724 |
|
|
2022
Q3 | $1.38M | Buy |
+48,939
| New | +$1.38M | 0.04% | 397 |
|
|
2022
Q2 | – | Sell |
-9,868
| Closed | -$336K | – | 530 |
|
|
2022
Q1 | $336K | Buy |
9,868
+2,724
| +38% | +$92.8K | 0.01% | 420 |
|
|
2021
Q4 | $276K | Buy |
+7,144
| New | +$276K | 0.02% | 488 |
|